Kinase inhibitors for advanced medullary thyroid carcinoma
The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2012-01-01
|
| Series: | Clinics |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012001300021 |
| _version_ | 1818246329160171520 |
|---|---|
| author | Martin Schlumberger Marie-Hélène Massicotte Camila L. Nascimento Cécile Chougnet Eric Baudin Sophie Leboulleux |
| author_facet | Martin Schlumberger Marie-Hélène Massicotte Camila L. Nascimento Cécile Chougnet Eric Baudin Sophie Leboulleux |
| author_sort | Martin Schlumberger |
| collection | DOAJ |
| description | The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered. |
| first_indexed | 2024-12-12T14:47:05Z |
| format | Article |
| id | doaj.art-286071de4fe2409488c46883dd3be47e |
| institution | Directory Open Access Journal |
| issn | 1807-5932 1980-5322 |
| language | English |
| last_indexed | 2024-12-12T14:47:05Z |
| publishDate | 2012-01-01 |
| publisher | Elsevier España |
| record_format | Article |
| series | Clinics |
| spelling | doaj.art-286071de4fe2409488c46883dd3be47e2022-12-22T00:21:05ZengElsevier EspañaClinics1807-59321980-53222012-01-016712512910.6061/clinics/2012(Sup01)21Kinase inhibitors for advanced medullary thyroid carcinomaMartin SchlumbergerMarie-Hélène MassicotteCamila L. NascimentoCécile ChougnetEric BaudinSophie LeboulleuxThe recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012001300021Thyroid NeoplasmsMolecular Targeted Therapy |
| spellingShingle | Martin Schlumberger Marie-Hélène Massicotte Camila L. Nascimento Cécile Chougnet Eric Baudin Sophie Leboulleux Kinase inhibitors for advanced medullary thyroid carcinoma Clinics Thyroid Neoplasms Molecular Targeted Therapy |
| title | Kinase inhibitors for advanced medullary thyroid carcinoma |
| title_full | Kinase inhibitors for advanced medullary thyroid carcinoma |
| title_fullStr | Kinase inhibitors for advanced medullary thyroid carcinoma |
| title_full_unstemmed | Kinase inhibitors for advanced medullary thyroid carcinoma |
| title_short | Kinase inhibitors for advanced medullary thyroid carcinoma |
| title_sort | kinase inhibitors for advanced medullary thyroid carcinoma |
| topic | Thyroid Neoplasms Molecular Targeted Therapy |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012001300021 |
| work_keys_str_mv | AT martinschlumberger kinaseinhibitorsforadvancedmedullarythyroidcarcinoma AT mariehelenemassicotte kinaseinhibitorsforadvancedmedullarythyroidcarcinoma AT camilalnascimento kinaseinhibitorsforadvancedmedullarythyroidcarcinoma AT cecilechougnet kinaseinhibitorsforadvancedmedullarythyroidcarcinoma AT ericbaudin kinaseinhibitorsforadvancedmedullarythyroidcarcinoma AT sophieleboulleux kinaseinhibitorsforadvancedmedullarythyroidcarcinoma |